// App-Quantinova.ai

TCT-343 : Variations in Efficacy and Safety Over Time Between Drug-Coated Balloon and Drug-Eluting Stent for the Treatment of Coronary In-Stent Restenosis: Results from the DAEDALUS Study.

Researchers

Presenter

  • Daniele Giacoppo

Principal Investigators

  • Fernando Alfonso

  • Bo Xu

  • Bimmer Claessen

  • Tom Adriaenssens

  • Christoph Naber

  • Maria Perez-Vizcayno

  • Do-Yoon Kang

  • Ralf Degenhardt

  • Leos Pleva

  • Jan Baan

  • Duk-Woo Park

  • Runlin Gao

  • Jose PS. Henriques

  • Seung-Jung Park

  • Adnan Kastrati

  • Robert Byrne

Medical Centers

  • Deutsches Herzzentrum, Munich, Germany

  • Hospital Universitario de la Princesa, Madrid, Spain

  • Herz-Kreislauf-Zentrum, Rotenburg an der Fulda, Germany

  • Asan Medical Center, Seoul, Korea, Republic of

  • Deutsches Herzzentrum Munchen, Technische Universitat Munchen, Munich, Germany

  • Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  • Academic Medical Center, Amsterdam, Netherlands

  • Ostrava University Hospital, Ostrava-Poruba, Czech Republic

  • Contilia Heart and Vascular Center, Essen, Germany

  • UNIVERSITY HOSPITALS LEUVEN, Leuven, Belgium

  • Hospital Clínico San Carlos, FIC, Madrid, Spain

  • Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing, China

Locations

  • Germany

  • Netherlands

  • Republic of South Korea

  • Czech Republic

  • Spain

  • Belgium

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved